# Moderna vs Regeneron Pharmaceuticals: stocks compared

URL: https://funkfolio.com/compare/mrna-vs-regn

> Moderna ($83.7B) and Regeneron Pharmaceuticals ($99.1B, P/E 21.1) compared: size, valuation, margins, debt, cash and price change.

---

## Moderna vs Regeneron Pharmaceuticals

Moderna (MRNA), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Regeneron Pharmaceuticals is worth $99.1B on the stock market and Moderna $83.7B: Regeneron Pharmaceuticals is valued at 18% more. Moderna's operating margin in its latest fiscal year was -158% and Regeneron Pharmaceuticals's 24.9%. Over the past year Moderna's share price has moved +764% and Regeneron Pharmaceuticals's +31.3%.

### Key facts

- **Moderna market value:** $83.7B
- **Regeneron Pharmaceuticals market value:** $99.1B
- **Regeneron Pharmaceuticals P/E:** 21.1
- **Moderna revenue:** $1.9B FY to 2025-12-31
- **Regeneron Pharmaceuticals revenue:** $14.3B FY to 2025-12-31
- **Superinvestors holding both:** 0

Market values as of 18 Nov 2026, 03:50 UTC.

Moderna vs Regeneron Pharmaceuticals: every measure side by side

| Measure | Moderna | Regeneron Pharmaceuticals |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $83.7B lower | $99.1B higher |
| Revenue | $1.9B lower | $14.3B higher |
| Earnings | -$2.8B lower | $4.5B higher |
| Employees | 4,700 lower | 15,410 higher |
| Total assets | $12.3B lower | $40.6B higher |
| Valuation |  |  |
| P/E | — | 21.1 |
| P/S | 43.0 higher | 6.9 lower |
| P/B | 12.2 higher | 2.9 lower |
| Dividend yield | 0.00% lower | 0.39% higher |
| Profitability |  |  |
| Operating margin | -158% lower | 24.9% higher |
| Balance sheet |  |  |
| Net assets | $8.7B lower | $31.3B higher |
| Total liabilities | $3.7B lower | $9.3B higher |
| Total debt | $590M lower | $2B higher |
| Cash on hand | $2.6B lower | $3.1B higher |
| Price change |  |  |
| Today | -3.93% lower | +0.56% higher |
| 1 year | +764% higher | +31.3% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Moderna 835.2, Regeneron Pharmaceuticals 136.0.

- Moderna (MRNA)
- Regeneron Pharmaceuticals (REGN)

Moderna and Regeneron Pharmaceuticals share prices over one year, rebased to 100: Moderna ends at 835.2, Regeneron Pharmaceuticals at 136.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | MRNA | REGN |
| --- | --- | --- |
| Nov 28, 2025 | 104.9 | 110.8 |
| Dec 31, 2025 | 119.1 | 109.6 |
| Jan 30, 2026 | 178.0 | 105.3 |
| Feb 27, 2026 | 216.4 | 111.0 |
| Mar 31, 2026 | 205.2 | 109.7 |
| Apr 30, 2026 | 185.5 | 100.4 |
| May 29, 2026 | 190.6 | 87.3 |
| Jun 30, 2026 | 282.8 | 88.5 |
| Jul 31, 2026 | 221.4 | 108.3 |
| Aug 31, 2026 | 566.8 | 113.5 |
| Sep 30, 2026 | 777.7 | 107.7 |
| Oct 30, 2026 | 895.5 | 131.7 |
| Nov 17, 2026 | 835.2 | 136.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (0)

None of the tracked investors.

#### Moderna only (2)

- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 2.1%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.4%

#### Regeneron Pharmaceuticals only (10)

- [Mason Hawkins](https://funkfolio.com/gurus/mason-hawkins) 5.0%
- [Harry Burn](https://funkfolio.com/gurus/harry-burn) 3.0%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.9%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.5%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.3%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.2%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.1%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.1%

Percentages are each holding's share of that investor's reported portfolio. [Who owns MRNA](https://funkfolio.com/stock/MRNA/superinvestors) · [Who owns REGN](https://funkfolio.com/stock/REGN/superinvestors)

### More on Moderna

- [Moderna (MRNA) stock page](https://funkfolio.com/stock/MRNA)
- [Moderna market cap](https://funkfolio.com/stock/MRNA/market-cap)
- [Moderna revenue](https://funkfolio.com/stock/MRNA/revenue)
- [Moderna P/E ratio](https://funkfolio.com/stock/MRNA/pe-ratio)
- [Moderna operating margin](https://funkfolio.com/stock/MRNA/operating-margin)
- [Moderna total debt](https://funkfolio.com/stock/MRNA/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Regeneron Pharmaceuticals

- [Regeneron Pharmaceuticals (REGN) stock page](https://funkfolio.com/stock/REGN)
- [Regeneron Pharmaceuticals market cap](https://funkfolio.com/stock/REGN/market-cap)
- [Regeneron Pharmaceuticals revenue](https://funkfolio.com/stock/REGN/revenue)
- [Regeneron Pharmaceuticals P/E ratio](https://funkfolio.com/stock/REGN/pe-ratio)
- [Regeneron Pharmaceuticals operating margin](https://funkfolio.com/stock/REGN/operating-margin)
- [Regeneron Pharmaceuticals total debt](https://funkfolio.com/stock/REGN/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Moderna against its closest peers

- [Moderna vs CVS Health](https://funkfolio.com/compare/cvs-vs-mrna)
- [Moderna vs Sanofi](https://funkfolio.com/compare/mrna-vs-sny)
- [Moderna vs HCA Healthcare](https://funkfolio.com/compare/hca-vs-mrna)
- [Moderna vs GSK](https://funkfolio.com/compare/gsk-vs-mrna)

#### Regeneron Pharmaceuticals against its closest peers

- [Regeneron Pharmaceuticals vs Elevance Health](https://funkfolio.com/compare/elv-vs-regn)
- [Regeneron Pharmaceuticals vs GSK](https://funkfolio.com/compare/gsk-vs-regn)
- [Regeneron Pharmaceuticals vs HCA Healthcare](https://funkfolio.com/compare/hca-vs-regn)
- [Regeneron Pharmaceuticals vs CVS Health](https://funkfolio.com/compare/cvs-vs-regn)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Moderna or Regeneron Pharmaceuticals?**

By market value, Regeneron Pharmaceuticals is the larger: $99.1B against $83.7B for Moderna. By revenue in its latest fiscal year, Regeneron Pharmaceuticals is the larger: $14.3B against $1.9B for Moderna.

**Which has the higher operating margin?**

Regeneron Pharmaceuticals: 24.9%, against -158% for Moderna. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Regeneron Pharmaceuticals: 0.39%, against 0.00% for Moderna. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Regeneron Pharmaceuticals: $2B, against $590M for Moderna. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Moderna and Regeneron Pharmaceuticals?**

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold Moderna and 10 hold Regeneron Pharmaceuticals.

### Cite this page

Funkfolio, “Moderna vs Regeneron Pharmaceuticals”, data as of 18 November 2026. https://funkfolio.com/compare/mrna-vs-regn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
